Oral CBD and THC for hip or knee osteoarthritis pain
Official title: The Effectiveness of Oral Cannabis Extracts for Osteoarthritic Pain: an Internal Pilot, Placebo Controlled, Blinded Randomized Trial
Run by University Health Network, Toronto · NCT06878417 · Data updated 2026-11-12
This study will test whether taking a daily oral CBD or THC capsule can reduce pain interference in adults aged 40–80 with hip or knee osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 80 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Health Network, Toronto Academic / other |
| Locations | 3 sites (Toronto, Ontario and 2 other locations) |
| Status | Recruiting |
| Started | January 29, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | February 28, 2027 |
| Registry record updated | July 16, 2026 |
| Trial ID | NCT06878417 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 40–80 years old with hip and/or knee osteoarthritis by ACR criteria, a PROMIS-PI SF-6a T-score ≥60, no recent changes to analgesics or OA treatments, able to self-report in English or French, and without recent cannabis use or contraindications are ideal candidates.
✕Probably not a fit
People with inflammatory arthritis, planned joint surgery or recent/planned joint injections, recent cannabis use or a history of cannabis use disorder, or contraindications to cannabinoids are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 40–80 with ACR-diagnosed hip or knee osteoarthritis who meet entry criteria will take either a CBD capsule, a THC capsule, or a matching placebo each day for 8 weeks and complete remote follow-ups. Participants keep a diary of study drug use and any additional pain medications, and outcomes include pain interference measured with PROMIS-PI. There are no required in-person clinic visits for follow-up. The trial is a feasibility step to inform the design, dosing, and delivery of a larger randomized trial of medical cannabis for OA pain.
Why it matters
Potential benefit: If successful, one or both cannabinoids could provide an additional option to reduce pain interference and improve daily function for people with hip or knee osteoarthritis.
How similar studies have gone: Prior small or low-quality studies of cannabinoids for chronic noncancer musculoskeletal pain have shown mixed or modest effects, so benefit for OA pain remains unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 40-80 years 2. Diagnosed with hip and/or knee osteoarthritis as per the American College of Rheumatology criteria 3. Experiencing moderate to severe pain interference as indicated by a PROMIS-PI SF-6a T-score ≥ 60 4. Have not initiated any new analgesics or osteoarthritis treatments in the previous 4 weeks 5. Able to self-report, understand and read English or French Exclusion Criteria: 1. Hip or knee surgery planned in the coming 4 months, 2. Injection into the affected joint(s) within the past 3 months (e.g., cortisone, plasma-rich protein, etc.), 3. Planned injection into the affected joint(s) during trial period, 4. Inflammatory arthritis (e.g., rheumatoid arthritis, Psoriatic arthritis, gout, etc.), 5. Contraindications to taking cannabis/cannabinoids, 6. Used nabilone or nabiximols in the last 30 days, 7. Used cannabis (medical or recreational) in the last 30 days (to allow sufficient washout), 8. A history of diagnosed cannabis use disorder or dependence, 9. Active substance use disorder, 10. Current DSM-V diagnosis of bipolar disorder, major depression, or psychosis, 11. An uncontrolled medical or major psychiatric disorder, 12. Currently on warfarin, 13. Known pregnancy or currently breastfeeding, 14. Men and women planning a pregnancy during the study or in the 12 weeks after stopping IPs 15. No fixed address or a plan to change addresses in the coming 4 months, 16. Known or suspected allergy to palm/coconut oil
Where it's running
-
University Health Network
Toronto, Ontario, Canada Recruiting -
Women's College Hospital
Toronto, Ontario, Canada Recruiting -
McGill University Health Centre/Montreal General Hospital
Montreal, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Dr. Hance Clarke, MD — University Health Network, Toronto
- Study coordinator: Sonal Thaker
- Email: sonalben.thaker@uhn.ca
- Phone: 1-416-340-4800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Different exercise programs to see how they affect muscle oxygenation in knee OA
In adults with knee osteoarthritis, this study tests three 6-week exercise programs to see how they influence muscle oxygenation and strength.
-
Collarless Actis hip stem for cementless hip replacement in Asian patients
This study tests how well a collarless Actis hip stem works in adults undergoing primary hip replacement, focusing on outcomes over five years in an East Asian population.
-
Intravenous dexamethasone for better pain control after hip replacement with a PENG block
This study tests whether giving dexamethasone through a vein, in 0, 4, or 8 mg doses, helps control pain after total hip arthroplasty when used with a PENG block.
-
Comparing barbed and conventional wound closure after hip or knee replacement
This study will test whether barbed sutures or conventional sutures lead to better wound healing and fewer complications for adults having primary or aseptic revision hip or knee replacement.
-
Repair versus partial meniscus removal for displaced bucket-handle tears
This project will see if repairing displaced bucket-handle meniscus tears leads to fewer repeat surgeries and less early knee osteoarthritis than removing the damaged part in people aged 15 and older with a locked knee.
-
Choose to Move Replacement Ready for people waiting for hip or knee replacement
This project will test whether the Choose to Move Replacement Ready program helps older adults on hip or knee replacement waitlists increase physical activity, improve mobility, and support psychosocial health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.